NCT07264101

Brief Summary

This cross-sectional observational study aims to evaluate the validity and reliability of the Four Square Step Test (FSST) in individuals with rheumatoid arthritis. In addition, the study will investigate the associations between FSST performance and clinical parameters including disease activity, quality of life, pain, and muscle strength. All assessments will be conducted according to a pre-defined standardized protocol. The order of measurement tools will be randomized to minimize potential bias, and sufficient rest intervals will be provided between tests to prevent fatigue and performance effects. Participants will include individuals aged 18-65 years with a diagnosis of rheumatoid arthritis according to the ACR/EULAR 2010 classification criteria, who have been followed for at least 6 months, have had no major changes in treatment regimen in the last 4 weeks (e.g., initiation or change of DMARDs/biologics, high-dose steroid increase), can walk at least 10 meters independently, have a Mini-Mental State Examination score of 24 or higher, and are able to follow verbal instructions in Turkish to comply with study procedures. Appropriate statistical methods will be applied to assess validity, reliability, and associations between FSST and clinical parameters.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
0mo left

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Dec 2025May 2026

First Submitted

Initial submission to the registry

November 20, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 4, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

November 20, 2025

Last Update Submit

December 17, 2025

Conditions

Keywords

Rheumatoid Arthritis (RA)Four Square Step Test (FSST)Balance

Outcome Measures

Primary Outcomes (1)

  • Four Square Step Test (FSST)

    The Four Square Step Test (FSST) is used to assess dynamic balance, specifically the ability to rapidly step over obstacles and change direction in a clinical setting. FSST is a quick and easily administered test that evaluates an individual's capacity to step in multiple directions over low obstacles. Four squares are created by intersecting lines at right angles, with each side approximately 90 cm in length. Low obstacles of 2.5 cm height are placed along the square boundaries. The participant starts in the lower-left square with feet together. In the first phase, the participant steps clockwise through each square-forward, right, backward, and left-returning to the starting position. The same sequence is then repeated counterclockwise. Participants must step into each square with both feet. After one practice trial, the test is performed twice, and completion times are recorded in seconds. The fastest time is considered the FSST score, with lower times indicating better dynamic bal

    Two assesstment ( one at baseline and one in the afternoon)

Secondary Outcomes (7)

  • Disease Activity Score-28 (DAS-28)

    Baseline (First assessment)

  • Numeric Rating Scale (NRS)

    Baseline (First assesstment)

  • Rheumatoid Arthritis Quality of Life (RAQoL) scale

    Baseline (First assesstment)

  • Mini-Balance Evaluation Systems Test (Mini-BESTest)

    Baseline (First assesstment)

  • Berg Balance Test(BBS)

    Baseline ( First assessment)

  • +2 more secondary outcomes

Study Arms (1)

Rheumatoid Arthritis Group

Participants will consist of adult individuals aged 18-65 years with a diagnosis of rheumatoid arthritis based on the ACR/EULAR classification criteria. Clinical assessments will include the Four Square Step Test (FSST), Berg Balance Scale, Mini-BESTest, handgrip strength using a dynamometer. Disease activity (DAS28), pain intensity, quality of life, and history of falls will also be recorded. This study is purely observational and cross-sectional in nature, and no therapeutic intervention will be applied to participants.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants aged 18-65 years with rheumatoid arthritis (RA) will be included in this study.

You may qualify if:

  • Age between 18 and 65 years
  • Diagnosis of rheumatoid arthritis according to ACR/EULAR 2010 criteria
  • No major changes in treatment regimen (e.g., initiation or modification of DMARDs/biologics, high-dose steroid increase) within the last 4 weeks
  • Ability to walk at least 10 meters without assistance
  • Mini-Mental State Examination (MMSE) score ≥ 24
  • Ability to understand and follow instructions in Turkish

You may not qualify if:

  • Participants who cannot understand or follow verbal instructions in Turkish
  • Participants with a history of neurological, vestibular, or serious orthopedic disease
  • Participants whose physical participation is limited due to acute infection or systemic disease
  • Participants who have had lower extremity surgery or a history of serious injury within the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University Turgut Ozal Medical Center

Malatya, Turkey (Türkiye)

RECRUITING

Related Publications (20)

  • Vilarinho R, Montes AM, Noites A, Silva F, Melo C. Reference values for the 1-minute sit-to-stand and 5 times sit-to-stand tests to assess functional capacity: a cross-sectional study. Physiotherapy. 2024 Sep;124:85-92. doi: 10.1016/j.physio.2024.01.004. Epub 2024 Jan 20.

    PMID: 38875841BACKGROUND
  • Du W, Cornett KMD, Donlevy GA, Burns J, McKay MJ. Variability between Different Hand-Held Dynamometers for Measuring Muscle Strength. Sensors (Basel). 2024 Mar 14;24(6):1861. doi: 10.3390/s24061861.

    PMID: 38544123BACKGROUND
  • Zonzini Gaino J, Barros Bertolo M, Silva Nunes C, de Morais Barbosa C, Sachetto Z, Davitt M, de Paiva Magalhaes E. Disease-related outcomes influence prevalence of falls in people with rheumatoid arthritis. Ann Phys Rehabil Med. 2019 Mar;62(2):84-91. doi: 10.1016/j.rehab.2018.09.003. Epub 2018 Sep 29.

    PMID: 30278237BACKGROUND
  • Wagner S, Bring A, Asenlof P. Construct validity of the Mini-BESTest in individuals with chronic pain in specialized pain care. BMC Musculoskelet Disord. 2023 May 17;24(1):391. doi: 10.1186/s12891-023-06504-9.

    PMID: 37198616BACKGROUND
  • Tijhuis GJ, de Jong Z, Zwinderman AH, Zuijderduin WM, Jansen LM, Hazes JM, Vliet Vlieland TP. The validity of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire. Rheumatology (Oxford). 2001 Oct;40(10):1112-9. doi: 10.1093/rheumatology/40.10.1112.

    PMID: 11600740BACKGROUND
  • Robinson CL, Phung A, Dominguez M, Remotti E, Ricciardelli R, Momah DU, Wahab S, Kim RS, Norman M, Zhang E, Hasoon J, Orhurh V, Viswanath O, Yazdi C, Chen GH, Simopoulos TT, Gill J. Pain Scales: What Are They and What Do They Mean. Curr Pain Headache Rep. 2024 Jan;28(1):11-25. doi: 10.1007/s11916-023-01195-2. Epub 2023 Dec 7.

    PMID: 38060102BACKGROUND
  • Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009 Jun;68(6):954-60. doi: 10.1136/ard.2007.084459. Epub 2008 May 19.

    PMID: 18490431BACKGROUND
  • Kim J, Kim I, Kim YE, Koh SB. The Four Square Step Test for Assessing Cognitively Demanding Dynamic Balance in Parkinson's Disease Patients. J Mov Disord. 2021 Sep;14(3):208-213. doi: 10.14802/jmd.20146. Epub 2021 May 26.

    PMID: 34030434BACKGROUND
  • Kocaman H, Canli M, Alkan H, Yildirim H, Yildiz NT. The Reliability and Validity of the Modified Four Square Step Test in Individuals with Anterior Cruciate Ligament Reconstruction. Indian J Orthop. 2023 Sep 13;57(11):1819-1825. doi: 10.1007/s43465-023-00993-5. eCollection 2023 Nov.

    PMID: 37881277BACKGROUND
  • Horata ET, Eken F, Yesil M, Ozcan O. Validity and reliability of the modified four square step test in total HIP arthroplasty. J Bodyw Mov Ther. 2024 Oct;40:345-349. doi: 10.1016/j.jbmt.2024.04.028. Epub 2024 Apr 16.

    PMID: 39593608BACKGROUND
  • Verma A, Samuel AJ, Aranha VP. The four square step test in children with Down syndrome: Reliability and concurrent validity. J Pediatr Neurosci. 2014 Sep-Dec;9(3):221-6. doi: 10.4103/1817-1745.147573.

    PMID: 25624923BACKGROUND
  • Aldirmaz E, Ugur F, Yilmaz O, Karaduman A, Alemdaroglu-Gurbuz I. A New Instrument to Assess Dynamic Balance in Children with Duchenne Muscular Dystrophy: Four Square Step Test and Its Validity, Reliability and Feasibility. Dev Neurorehabil. 2023 Jan;26(1):27-36. doi: 10.1080/17518423.2022.2143924. Epub 2022 Nov 11.

    PMID: 36367327BACKGROUND
  • Tanrıöğer Soyuer F. Valıdıty And Relıabılıty Of "Four-Square Step Test" In Adolescent Cerebral Palsy2018.

    BACKGROUND
  • Taylor S, Pemberton S, Barker K. Validity of the four-square step test in persons with haemophilia. Haemophilia. 2022 Mar;28(2):334-342. doi: 10.1111/hae.14482. Epub 2022 Jan 12.

    PMID: 35020243BACKGROUND
  • Toprak CS, Duruoz MT, Gunduz OH. Static and Dynamic Balance Disorders in Patients With Rheumatoid Arthritis and Relationships With Lower Extremity Function and Deformities: A Prospective Controlled Study. Arch Rheumatol. 2018 Jan 15;33(3):328-334. doi: 10.5606/ArchRheumatol.2018.6720. eCollection 2018 Sep.

    PMID: 30632523BACKGROUND
  • Aydog E, Bal A, Aydog ST, Cakci A. Evaluation of dynamic postural balance using the Biodex Stability System in rheumatoid arthritis patients. Clin Rheumatol. 2006 Jul;25(4):462-7. doi: 10.1007/s10067-005-0074-4. Epub 2005 Oct 25.

    PMID: 16247584BACKGROUND
  • Wasserman A. Rheumatoid Arthritis: Common Questions About Diagnosis and Management. Am Fam Physician. 2018 Apr 1;97(7):455-462.

    PMID: 29671563BACKGROUND
  • Wu D, Li Y, Xu R. Can pyroptosis be a new target in rheumatoid arthritis treatment? Front Immunol. 2023 Jun 22;14:1155606. doi: 10.3389/fimmu.2023.1155606. eCollection 2023.

    PMID: 37426634BACKGROUND
  • Yetis M, Kocaman H, Canli M, Alkan H, Yildirim H, Yildiz NT, Kuzu S. Validity and reliability of the Modified Four Square Step Test in individuals with ankle sprain. J Orthop Surg Res. 2024 Mar 15;19(1):182. doi: 10.1186/s13018-024-04664-5.

    PMID: 38491530BACKGROUND
  • Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016 Oct 22;388(10055):2023-2038. doi: 10.1016/S0140-6736(16)30173-8. Epub 2016 May 3.

    PMID: 27156434BACKGROUND

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Zeynal Yasacı

    Inonü University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor lecturer

Study Record Dates

First Submitted

November 20, 2025

First Posted

December 4, 2025

Study Start

December 15, 2025

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

May 15, 2026

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Participant data will be securely stored by the investigators and may be shared with authorized personnel if deemed necessary, in accordance with applicable privacy regulations.

Locations